PALI Stock: Palisade Bio, Inc. Stock Price, Analysis & Insights
Get live PALI stock price $1.70, comprehensive Palisade Bio, Inc. stock analysis, charts, news, and expert forecast. Real-time PALI stock data and investment insights.
Loading chart data...
Palisade Bio, Inc. (PALI) Overview
Palisade Bio, Inc. (PALI) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, PALI trades at $1.70 with a market capitalization of 294.22M . Over the past 52 weeks, PALI has traded between $0.53 and $2.86 , with the current price positioned at approximately 50% of this range . The stock currently trades at a ...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 294.22M
- Current price: $1.70
- 52-week range: $0.53 - $2.86
- P/E ratio: 14.13
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Palisade Bio, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, advancing, and bringing to market orally administered treatments for significant conditions stemming from a compromised gastrointestinal mucosal barrier. The comp...
Company Information
- CEO
- J. D. Finley
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 8
Contact Information
- Website
- https://www.palisadebio.com
- Address
- 5800 Armada Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 14.1)
✓ Higher growth potential with elevated volatility (Beta: 1.54)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Palisade Bio, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Palisade Bio, Inc.
- ⚠Investors should consider how Palisade Bio, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
294.22M
P/E Ratio (TTM)
14.13
Beta
1.54
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PALI with peer companies:
- Price
- $5.83
- Market cap
- 672.97K
- Price
- $6.75
- Market cap
- 26.62M
- Price
- $3.05
- Market cap
- 5.74M
- Price
- $0.44
- Market cap
- 5.80M
- Price
- $0.55
- Market cap
- 6.15M
- Price
- $1.95
- Market cap
- 18.57M
- Price
- $2.85
- Market cap
- 13.58M
- Price
- $1.26
- Market cap
- 16.71M
- Price
- $0.77
- Market cap
- 31.86M
- Price
- $2.11
- Market cap
- 4.78M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.